MARCHYMEL Trademark

Trademark Overview


On Friday, January 4, 2019, a trademark application was filed for MARCHYMEL with the United States Patent and Trademark Office. The USPTO has given the MARCHYMEL trademark a serial number of 88250286. The federal status of this trademark filing is REGISTERED as of Tuesday, November 3, 2020. This trademark is owned by Life Science Institute, Inc.. The MARCHYMEL trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries
marchymel

General Information


Serial Number88250286
Word MarkMARCHYMEL
Filing DateFriday, January 4, 2019
Status700 - REGISTERED
Status DateTuesday, November 3, 2020
Registration Number6187628
Registration DateTuesday, November 3, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements


Goods and ServicesCells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries
Translation of Words in MarkThe wording "MARCHYMEL" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLife Science Institute, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 100-8251
JP

Party NameLife Science Institute, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 100-8251
JP

Party NameLife Science Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 100-8251
JP

Trademark Events


Event DateEvent Description
Tuesday, November 3, 2020REGISTERED-PRINCIPAL REGISTER
Monday, September 28, 20201(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, September 28, 2020NOTICE OF ALLOWANCE CANCELLED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 10, 2020TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 3, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, September 9, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 9, 2019LETTER OF SUSPENSION E-MAILED
Monday, September 9, 2019SUSPENSION LETTER WRITTEN
Wednesday, August 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 28, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 28, 2019ASSIGNED TO LIE
Tuesday, August 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 1, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 1, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 21, 2019NON-FINAL ACTION E-MAILED
Thursday, February 21, 2019NON-FINAL ACTION WRITTEN
Wednesday, February 20, 2019ASSIGNED TO EXAMINER
Saturday, January 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 8, 2019NEW APPLICATION ENTERED IN TRAM